Clinical trials
Recruiting Phase 1/2 Fallopian Tube Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
14 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2018 | 1 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 3 |
| 2023 | 3 |
| 2025 | 2 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 14 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Beijing Biotech | 2 |
| Regeneron Pharmaceuticals | 2 |
| Artios Pharma Ltd | 1 |
| AstraZeneca | 1 |
| Avenzo Therapeutics, Inc. | 1 |
| Day One Biopharmaceuticals, Inc. | 1 |
| Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc. | 1 |
| Genmab | 1 |
| Imunon | 1 |
| Medicenna Therapeutics, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fallopian Tube Neoplasms | 14 |
| Ovarian Neoplasms | 11 |
| Endometrial Neoplasms | 7 |
| Triple Negative Breast Neoplasms | 5 |
| Breast Neoplasms | 4 |
| Carcinoma, Ovarian Epithelial | 4 |
| Recurrence | 3 |
| Carcinoma, Non-Small-Cell Lung | 2 |
| Colorectal Neoplasms | 2 |
| Neoplasm Metastasis | 2 |
Trials
Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.